A role for endothelial NMDA receptors in the pathophysiology of schizophrenia
- 11 November 2020
- journal article
- research article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 249, 63-73
- https://doi.org/10.1016/j.schres.2020.10.004
Abstract
No abstract availableFunding Information
- Canadian Institutes of Health Research
- National Institute of Mental Health
This publication has 123 references indexed in Scilit:
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophreniaMolecular Psychiatry, 2012
- Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophreniaTranslational Psychiatry, 2011
- Coactivation of NMDA Receptors by Glutamate and d-Serine Induces Dilation of Isolated Middle Cerebral ArteriesJournal of Cerebral Blood Flow & Metabolism, 2011
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for TreatmentNeuropsychopharmacology, 2011
- Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs)Schizophrenia Research, 2011
- High dose D-serine in the treatment of schizophreniaSchizophrenia Research, 2010
- Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysisEuropean Journal of Human Genetics, 2009
- D-Amino acid oxidase activity and expression are increased in schizophreniaMolecular Psychiatry, 2008
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008
- An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endotheliumThe Journal of Experimental Medicine, 2006